Estudio en fase II de navelbine + cisplatino + etoposido en el tratamiento del cáncer de pulmón no células pequeñas inoperable. / [Phase II trial with navelbine + cisplatin + etoposide in the treatment of inoperable non-small cell lung carcinoma]
Rev. Fac. Cienc. Méd. (Córdoba)
; 53(1): 27-32, 1995.
Article
em Es
| BINACIS
| ID: bin-37170
Biblioteca responsável:
AR32.1
ABSTRACT
40 patients with advanced non-small cell lung cancer not previously treated were included in a study at phase II with vinorelbine 20 mg/Sq.m days 1 and 8, etoposide 60 mg/sq.m days 1-3 and cisplatin 75 mg/sq.m day 1 each 28 days for 6 cycles. There were 31 men and 9 women, being the average age of 54 years, with [quot ]performance Status[quot ] grade 0-2. All of them could be evaluated for toxicity and 31 for responsiveness. 10 patients were in stage IIIb and 21 at stage IV. 42
Buscar no Google
Coleções:
06-national
/
AR
Base de dados:
BINACIS
Idioma:
Es
Revista:
Rev. Fac. Cienc. Méd. (Córdoba)
Ano de publicação:
1995
Tipo de documento:
Article
País de publicação:
Argentina